Powder & Bulk Solids is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Arkema Parts Ways with Phosphorous Derivatives Firm Fabex

Image courtesy of Arkema arkema_building_logo_image.jpg
Representative image
The company said a divestiture was proposed because the business has “little integration” with its other activities.

Specialty materials and chemicals manufacturer Arkema announced a proposed transaction Friday to divest its phosphorous derivatives business Fabex to Belgian firm Prayon. Fabex is part of Arkema’s Performance Additives business line.

The phosphorous derivatives company has “little integration” with Arkema’s other activities, the firm detailed in a release. Fabex produces high purity phosphoric acid, sodium hypophosphite, and derivatives used in the electronics and pharmaceutical industries at a facility in Switzerland.

Arkema said the deal is slated to reach completed in the first quarter of 2023 following a consultation process with employee representative bodies in France and approval by Swiss authorities.

59 Fabex employees are expected to join Pravon when the sale closes.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.